000 | 01595 a2200433 4500 | ||
---|---|---|---|
005 | 20250516145858.0 | ||
264 | 0 | _c20131119 | |
008 | 201311s 0 0 eng d | ||
022 | _a1865-3774 | ||
024 | 7 |
_a10.1007/s12185-013-1333-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGandhi, S | |
245 | 0 | 0 |
_aAllogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia. _h[electronic resource] |
260 |
_bInternational journal of hematology _cMay 2013 |
||
300 |
_a573-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAlemtuzumab |
650 | 0 | 4 |
_aAnemia, Aplastic _xcomplications |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 | _aAntigens, CD |
650 | 0 | 4 | _aAntigens, Neoplasm |
650 | 0 | 4 | _aCD52 Antigen |
650 | 0 | 4 |
_aGlycoproteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInfections _xetiology |
650 | 0 | 4 | _aTransplantation Conditioning |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKulasekararaj, A G | |
700 | 1 | _aMufti, G J | |
700 | 1 | _aMarsh, J C W | |
773 | 0 |
_tInternational journal of hematology _gvol. 97 _gno. 5 _gp. 573-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12185-013-1333-9 _zAvailable from publisher's website |
999 |
_c22713583 _d22713583 |